drug · protein
patient view →nogapendekin alfa
pre_registrationupdated 2mo agoby $IBRX ImmunityBio, Inc.🔗 ChEMBL
community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 19 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that